Mirae Asset Global Investments’s Precision BioSciences DTIL Stock Holding History

Mirae Asset Global Investments’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,188	Closed	-$480K	–	2406
2022 Q1	$480K	Sell	5,188 -958	-16%	-$130K	﹤0.01%	1461
2021 Q4	$1.36M	Buy	6,146 +1,598	+35%	+$446K	﹤0.01%	1211
2021 Q3	$1.57M	Buy	4,548 +854	+23%	+$289K	﹤0.01%	1174
2021 Q2	$1.39M	Buy	3,694 +527	+17%	+$158K	﹤0.01%	1162
2021 Q1	$984K	Buy	3,167 +1,447	+84%	+$507K	﹤0.01%	1134
2020 Q4	$431K	Buy	1,720 +625	+57%	+$153K	﹤0.01%	1358
2020 Q3	$203K	Buy	1,095 +344	+46%	+$68.4K	﹤0.01%	1428
2020 Q2	$187K	Buy	+751	New	+$164K	﹤0.01%	1405

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mirae Asset Global Investments's DTIL Position: Q2 2022 in Review

Mirae Asset Global Investments sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 5,188 shares — an estimated $480K sold.

Mirae Asset Global Investments first reported a position in DTIL in Q2 2020 and held it in 8 quarters. The position peaked at $1.57M in Q3 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

Mirae Asset Global Investments reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
Mirae Asset Global Investments sold 5,188 Precision BioSciences shares in Q2 2022, an estimated $480K.
Mirae Asset Global Investments first reported a position in Precision BioSciences in Q2 2020 and held it in 8 quarters.
Mirae Asset Global Investments's Precision BioSciences position peaked at $1.57M in Q3 2021.
119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Mirae Asset Global Investments's 13F filing for Q2 2022, filed 26 Jul 2022.